Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study.

Affiliation

UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; Institute of Cellular Medicine, Newcastle University, Newcastle, UK. Electronic address: [Email]

Abstract

Venlafaxine is a serotonin noradrenaline reuptake inhibitor used to treat major depressive episodes and anxiety disorders. The primary aim of this study was to investigate spontaneous abortion risks following gestational exposure.

Keywords

Birth defects,Congenital anomaly,Depression,Fetal growth,Fetotoxic effects,Fetus,Low birth weight,Miscarriage,Pregnancy,Prematurity,Preterm delivery,Small for gestational age,Spontaneous abortion,Teratogen,Venlafaxine,